重要提示：本材料不构成任何形式的要约、承诺或其他法律文件，亦非任何投资、法律或财务等方面的专业建议。过往业绩不预示 未来表现。投资须谨慎。 随着4月底临近，上市公司正迎来一季报的密集披露期。通常来讲，一季报作为上市公司每年首份公开 披露的业绩报告，对全年经营具有较强的前瞻性指引作用，因其不仅能够有效反映当下行业和公司的经 营状况，而且也能体现对未来经营的预期。我们以A股和港股总市值超过200亿元的所有上市企业，以 及其它具有行业代表性的公司为样本，梳理卖方分析师的盈利预测后，发现以下三个领域当前展现出了 明显的景气改善迹象： 1 AI产业链代表的科技行业 AI产业链代表的科技行业 数据来源：万得、淡水泉投资，选用数据区间为2024年1月1日至2025年4月18日。 超越经济周期、具有独立成长逻辑的优质公司 在宏观经济仍面临不确定性的大环境下，各行各业开始涌现出越来越多超越经济周期、具备独立成长逻 辑的优质公司。以储能产业链为例，虽然行业仍存在供给过剩的情况，但是部分龙头公司凭借全球化产 能布局在一定程度上规避关税影响，同时依靠先进技术带来的成本优势，海外产能充分受益于海外需求 增长带动的储能订单释放，形成量利 ...

Investment Rating - The report suggests a positive outlook for the home furnishing sector, new tobacco, and light consumer goods, while indicating a cautious stance on the paper packaging industry due to weak demand and unclear tariff trends [4][6][16][19]. Core Insights - The home furnishing sector shows signs of recovery with a 29.5% year-on-year increase in retail sales in March, driven by consumption subsidies. However, Q1 earnings for many companies are expected to face pressure [6][13]. - The new tobacco sector is poised for growth as regulatory actions against illegal e-cigarettes in the U.S. may expand the compliant market, with companies like Smoore International showing strong confidence through significant share purchases [19]. - The paper packaging industry is currently experiencing weak pricing trends due to seasonal demand and uncertain tariff impacts, with recommendations to focus on companies with lower exposure to U.S. tariffs [16]. Summary by Sections Home Furnishing Sector - Domestic retail sales of furniture increased by 29.5% year-on-year in March, and 18.1% for the first three months of the year, reflecting the impact of consumption subsidies [6][13]. - Companies like Sophia and Gujia Home are highlighted for their strategic positioning and potential for earnings recovery, with Sophia's PE ratio at 12x indicating significant valuation upside [13]. - The report emphasizes the importance of focusing on domestic leaders with high dividend support and attractive valuations in the home furnishing sector [6][13]. New Tobacco Sector - The U.S. is increasing regulatory scrutiny on illegal e-cigarettes, which may benefit compliant brands and the overall market expansion [19]. - Smoore International is recommended due to its competitive positioning and growth potential in the heated tobacco product (HNB) segment, supported by its collaboration with British American Tobacco [19]. Paper Packaging Sector - The report notes a weak pricing environment for paper products, with prices for various types of paper remaining stable or declining slightly as of April 18 [16]. - The packaging sector is expected to benefit from new consumer electronics subsidies, with companies like Yutong Technology positioned favorably due to their limited exposure to U.S. tariffs [16]. Light Consumer Goods - The pet food sector shows strong growth, with a 23% increase in GMV for Q1, while baby diaper sales also saw a significant rise [17]. - The report highlights the potential for brands like Bubble Mart and Guibao Pet to capitalize on the growing domestic market and consumer trends [17]. Two-Wheel Vehicles - The sector is experiencing a positive trend driven by the "old-for-new" policy, with Q1 production up 25% year-on-year to 11 million units [18]. - The report suggests focusing on leading companies with integrated supply chains and strong product performance as the market continues to recover [18].

Investment Rating - The investment rating for the company is not explicitly stated in the provided documents, but the report indicates a positive outlook for the company's performance in the coming years, suggesting a favorable investment perspective [1][4]. Core Viewpoints - The company achieved a revenue of 21.606 billion yuan in 2024, representing a year-on-year increase of 2.7%, with a net profit attributable to shareholders of 1.988 billion yuan, up 5.7% year-on-year [1]. - The electric bicycle business showed steady growth, while the electric tricycle business performed exceptionally well, with electric tricycle sales increasing by 28.9% [2]. - The company is restructuring its product lineup to enhance market coverage and has implemented a "flagship product" strategy to attract target consumer groups [2]. - Profitability and operational efficiency are continuously improving, with a gross margin of 17.8% in 2024, up 1.3 percentage points year-on-year [3]. - The company is expected to benefit significantly from new national standards and trade-in policies in 2025, with projected net profits of 2.641 billion yuan, 3.073 billion yuan, and 3.440 billion yuan for 2025, 2026, and 2027 respectively [4]. Summary by Sections Financial Performance - In 2024, the company reported total revenue of 21.606 billion yuan, with a gross margin of 17.8% and a net profit of 1.988 billion yuan [1][3]. - The sales of electric bicycles and electric two-wheel motorcycles accounted for 85.5% of total revenue, with sales of 9.905 million units, a decrease of 3.7% year-on-year [2]. - The company’s operating cash flow for 2024 was 3.166 billion yuan, indicating strong cash generation capabilities [3]. Product Strategy - The company has launched strategic new products targeting various market segments, including fashionable products for women and high-end flagship models [2]. - The focus on product differentiation through high-end configurations and smart technology aims to solidify the company's market position [2]. Future Outlook - The company is expected to see stable sales growth in Q1 2025, with potential demand delays due to supply constraints [4]. - Long-term projections indicate a continuous improvement in profit margins and average selling prices due to optimized product structures and scale advantages [4].

Group 1: Pharmaceutical Industry - The tariff environment has limited short-term disruptions to the pharmaceutical industry, with a focus on the global competitiveness of domestic innovative drugs [2][17][19] - Domestic innovative drug companies have captured significant market shares, such as BTK inhibitors holding 75% and PD-1/PD-L1 monoclonal antibodies over 70% in the domestic market [2][17] - Several Chinese innovative drugs are entering a harvest phase, with Zebutine expected to achieve sales of $2.6 billion in 2024, reflecting a year-on-year growth of 105% [2][17] - A recommended list of leading biotech and pharmaceutical companies includes BeiGene, Innovent Biologics, and Hengrui Medicine among others [2][17] Group 2: Chemical Industry - Juhua Co., Ltd. - Juhua Co., Ltd. is expected to see significant growth in Q1 2025, with projected net profit ranging from 760 to 840 million yuan, representing a year-on-year increase of 145% to 171% [5][6][36] - The company benefits from a strong position in the refrigerant market, with a production quota of 34% for third-generation refrigerants [6][36] - The refrigerant segment has shown a substantial increase in both volume and price, with revenues reaching 2.618 billion yuan, up 64.63% year-on-year [6][36] Group 3: Aluminum Industry - China Aluminum Corporation - China Aluminum Corporation is projected to achieve a net profit of 3.4 to 3.6 billion yuan in Q1 2025, reflecting a year-on-year increase of 53% to 63% [8][10] - The company is enhancing its resource strategy and has a significant aluminum ore reserve of approximately 2.7 billion tons [8][10] - Expansion projects are underway, with a new 500,000-ton electrolytic aluminum capacity expected to come online in December 2024 [10]

Investment Rating - The investment rating for the company is "Buy" (maintained) [3] Core Views - The company is expected to benefit from multiple stimuli in 2025, including inventory replenishment, seasonal upgrades, and the trial sales of new national standards in the second half of the year. This is likely to enhance the market share and profitability of leading enterprises [7] - The company is projected to achieve revenue growth of 2.7% in 2024, followed by 21.9% in 2025 and 15.1% in 2026, with net profit growth of 6% in 2024, 24% in 2025, and 18% in 2026 [7] - The company is expected to maintain a dividend payout ratio of 40% in 2023, indicating further upside potential [7] Revenue Analysis - The company’s revenue for 2024 is forecasted at 216.1 billion yuan, representing a year-on-year increase of 2.7%. The net profit attributable to the parent company is expected to be 19.9 billion yuan, up 5.7% year-on-year [8] - For the first quarter of 2025, the company anticipates a revenue increase of 20-25%, with an estimated shipment volume of approximately 3 million units, reflecting a nearly 20% year-on-year growth [8] Profitability Analysis - The company is expected to maintain a recovery trend in profitability, with net profit margins projected to improve slightly in 2025 [7] - The forecasted net profit for 2025 is 24.69 billion yuan, which is a 24.2% increase compared to 2024 [10] Financial Projections - The company’s financial projections indicate a steady increase in revenue and net profit over the next few years, with significant growth expected in 2025 and 2026 [10] - The projected P/E ratios for 2024, 2025, and 2026 are 20, 16, and 14 respectively, suggesting a favorable valuation outlook [7][10]